Hermann Luebbert - 22 Aug 2022 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Executive Chairman, Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert
Issuer symbol
BFRI
Transactions as of
22 Aug 2022
Transactions value $
$0
Form type
4
Filing time
19 Sep 2022, 08:08:54 UTC
Previous filing
26 May 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFRI Common Stock Options Exercise +113K 113K 22 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Options Exercise $0 -113K -37.27% $0.00 191K 22 Aug 2022 Common Stock 113K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units covert into common stock on a one-for-one basis.
F2 On December 9, 2021, the reporting person was granted 113,379 restricted stock units, vesting on the six-month anniversary of the grant date.